Press Release EASD 2018: Domestic refrigerators may pose risk to insulin quality

New research being presented at this year’s European Association for the Study of Diabetes (EASD) Annual Meeting in Berlin, Germany (1–5 October), suggests that insulin is often stored at the wrong temperature in patients’ fridges at home, which could affect its potency.

Many injectable drugs and vaccines are highly sensitive to heat and cold and can perish if their temperature shifts a few degrees. To prevent loss of effectiveness, insulin must stay between 2–8°C/36–46°F in the refrigerator or 2–30°C/36–86°F when carried about the person in a pen or vial.
Individuals with diabetes often store insulin at home for several months before they use it, but little is known about how storage in domestic fridges impacts insulin quality.

To investigate how often insulin is stored outside the manufacturer’s recommended temperature range, Dr Katarina Braune from Charité — Universitätsmedizin Berlin in Germany in collaboration with Professor Lutz Heinemann (Science & Co) and the digital health company MedAngel BV monitored the temperature of insulin formulations stored in fridges at home and carried as a spare.

Between November 2016 and February 2018, 388 diabetes patients living in the USA and the EU placed temperature sensors (MedAngel ONE, www.medangel.co) either next to their insulin in the fridge and or their diabetes bag. Temperature data were automatically measured every 3 minutes (up to 480 times a day) before being sent to an app and recorded on a secure database. Temperature data were recorded for an average of 49 days.

Dr Katarina Braune and Laura Krämer presenting data on insulin storage at EASD 2018 press conference.

Analysis of 400 temperature logs (230 for refrigerated and 170 carried insulin) revealed that 315 (79%) contained deviations from the recommended temperature range. On average, insulin stored in the fridge was out of the recommended temperature range 11% of the time (equivalent to 2 hours and 34 mins a day). In contrast, insulin carried by patients was only outside recommendations for around 8 minutes a day. Importantly, freezing was an even bigger issue, with 66 sensors (17%) measuring temperatures below 0˚C (equivalent to 3 hours a month on average).

“Many people with diabetes are unwittingly storing their insulin wrong because of fluctuating temperatures in domestic refrigerators”, says Dr Braune.

“When storing your insulin in the fridge at home, always use a thermometer to check the temperature. Long-term storage conditions of insulin are known to have an impact on its blood-glucose lowering effect. For people living with insulin-dependent diabetes who take insulin several times a day via injections or continuously administer insulin with a pump, precise dosing is essential to achieve optimal therapeutic outcomes. Even gradual loss of potency introduces unnecessary variability in dosing. More research is needed to examine the extent to which temperature deviations during domestic storage affect insulin efficacy and patient outcomes.”

Authors Prof Lutz Heinemann (Science&Co, Neuss, Germany), Laura Krämer, Amin Zayani (MedAngel BV, The Netherlands) and Dr Katarina Braune (Charité Universitätsmedizin Berlin, Germany).

 

Corresponding Author:
Dr Katarina Braune, Department of Paediatric Endocrinology and Diabetes, Charité Universitaetsmedizin Berlin, Berlin Germany
katarina.braune@charite.de

 

About EASD
The European Association for the Study of Diabetes e.V. (EASD) is a non-profit, medical scientific association. It was founded in 1965 and its headquarters is based in Düsseldorf, Germany.
EASD holds its Annual Meeting in a different European city each year with more than 15,000 delegates from over 130 countries attending. The scientific programme includes more than 1,200 talks and presentations on the latest results in diabetes research by leading experts in the field. The 54th Annual Meeting of the European Association for the Study of Diabetes took place on 1–5 October 2018 in Berlin, Germany.

4
95
Amin Zayani
Oct 16, 2018
Amin Zayani
CEO and co-founder of MedAngel, solar energy engineer turned digital health entrepreneur by accident.
@AminfiBerlin

Leave A Comment